Aperio Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $373K | Buy |
32,727
+1,738
| +6% | +$19.8K | ﹤0.01% | 2093 |
|
2020
Q3 | $279K | Buy |
30,989
+3,507
| +13% | +$31.6K | ﹤0.01% | 2101 |
|
2020
Q2 | $284K | Sell |
27,482
-1,764
| -6% | -$18.2K | ﹤0.01% | 2049 |
|
2020
Q1 | $295K | Buy |
29,246
+6,923
| +31% | +$69.8K | ﹤0.01% | 1911 |
|
2019
Q4 | $297K | Sell |
22,323
-3,491
| -14% | -$46.4K | ﹤0.01% | 2067 |
|
2019
Q3 | $222K | Sell |
25,814
-5,478
| -18% | -$47.1K | ﹤0.01% | 2139 |
|
2019
Q2 | $342K | Buy |
31,292
+6,598
| +27% | +$72.1K | ﹤0.01% | 1969 |
|
2019
Q1 | $280K | Buy |
24,694
+2,865
| +13% | +$32.5K | ﹤0.01% | 2029 |
|
2018
Q4 | $189K | Sell |
21,829
-2,310
| -10% | -$20K | ﹤0.01% | 2147 |
|
2018
Q3 | $373K | Sell |
24,139
-1,156
| -5% | -$17.9K | ﹤0.01% | 1915 |
|
2018
Q2 | $405K | Buy |
25,295
+6,452
| +34% | +$103K | ﹤0.01% | 1849 |
|
2018
Q1 | $244K | Sell |
18,843
-943
| -5% | -$12.2K | ﹤0.01% | 2051 |
|
2017
Q4 | $248K | Buy |
19,786
+2,743
| +16% | +$34.4K | ﹤0.01% | 2051 |
|
2017
Q3 | $225K | Buy |
17,043
+1,267
| +8% | +$16.7K | ﹤0.01% | 2070 |
|
2017
Q2 | $249K | Buy |
15,776
+1,683
| +12% | +$26.6K | ﹤0.01% | 1996 |
|
2017
Q1 | $201K | Buy |
14,093
+1,531
| +12% | +$21.8K | ﹤0.01% | 2037 |
|
2016
Q4 | $161K | Buy |
+12,562
| New | +$161K | ﹤0.01% | 2038 |
|